Good morning :)
Place Order
Add to Watchlist
Home
Portfolio
Search
GoldGold
More

Fortis Malar Hospitals Ltd

FORTISMLR

Fortis Malar Hospitals Ltd

FORTISMLR
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹109 cr, stock is ranked 3,010
High RiskStock is 4.28x as volatile as Nifty
58.900.68% (+0.40)
58.900.68% (+0.40)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹109 cr, stock is ranked 3,010
High RiskStock is 4.28x as volatile as Nifty

How to use scorecard? Learn more

Health CareHospitals & Diagnostic Centres
SmallcapWith a market cap of ₹109 cr, stock is ranked 3,010
High RiskStock is 4.28x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
2.271.0470.34%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.926.650.51%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Fortis Malar Hospitals Limited is a provider of super specialty and multi-specialty healthcare services. It is engaged in establishing hospitals and clinics to conduct healthcare for the society in various branches of medicine.

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -4.34%, vs industry avg of 10.02%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.42% to 0.2%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 85.4%, vs industry avg of 42.9%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue137.64148.53157.63154.70123.0684.3493.5792.59123.8985.44
Raw Materialssubtract28.5329.4232.7733.0220.9714.3817.2611.908.7025.06
Power & Fuel Costsubtract2.762.742.823.193.042.672.592.932.47
Employee Costsubtract17.8320.1121.8723.4621.5518.2518.6019.4115.16
Selling & Administrative Expensessubtract28.9079.0040.1150.7233.8621.4320.5622.2517.49
Operating & Other expensessubtract46.108.4049.8736.6235.2318.8523.7324.8816.39
Depreciation/Amortizationsubtract3.163.944.214.3812.5312.8812.5312.159.363.97
Interest & Other Itemssubtract0.400.460.380.517.817.206.566.074.301.66
Taxes & Other Itemssubtract3.541.352.270.73-3.04-3.450.018.484.684.68
EPS3.451.671.781.10-4.74-4.19-4.41-8.2524.1526.67
DPS0.500.000.000.000.000.000.000.0042.5042.50
Payout ratio0.150.000.000.000.000.000.000.001.761.59
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2015

Annual report

PDF
FY 2016

Annual report

PDF
FY 2017

Annual report

PDF
FY 2018

Annual report

PDF
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF
FY 2024

Annual report

PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Fortis Malar Hospitals Ltd2.501.0470.34%
Max Healthcare Institute Ltd109.6813.800.13%
Apollo Hospitals Enterprise Ltd115.8114.220.22%
Fortis Healthcare Ltd86.066.020.15%

Price Comparison

Compare FORTISMLR with any stock or ETF
Compare FORTISMLR with any stock or ETF
FORTISMLR
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Increased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 2.39%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding62.71%0.07%0.00%0.00%37.22%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateJul 24, 2024

Final
Final | Div/Share: ₹2.50

Dividend/Share

₹2.50

Ex DateEx Date

Jul 24, 2024

Cash Dividend

Ex DateEx DateApr 23, 2024

Interim
Interim | Div/Share: ₹40.00

Dividend/Share

₹40.00

Ex DateEx Date

Apr 23, 2024

Cash Dividend

Ex DateEx DateSep 14, 2015

Final
Final | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Sep 14, 2015

Cash Dividend

Ex DateEx DateSep 19, 2013

Interim
Interim | Div/Share: ₹0.50

Dividend/Share

₹0.50

Ex DateEx Date

Sep 19, 2013

News & Opinions
Earnings
Fortis Malar Hospitals reports consolidated net profit of Rs 0.09 crore in the September 2024 quarter

Net profit of Fortis Malar Hospitals reported to Rs 0.09 crore in the quarter ended September 2024 as against net loss of Rs 1.79 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 as against Rs 18.15 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales018.15 -100 OPM %0-0.44 - PBDT0.090.93 -90 PBT0.09-1.79 LP NP0.09-1.79 LP Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Fortis Malar Hospitals announces board meeting date

Fortis Malar Hospitals will hold a meeting of the Board of Directors of the Company on 5 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live

Fortis Malar Hospitals reports consolidated net loss of Rs 0.06 crore in the June 2024 quarter

5 months agoBusiness Standard
Earnings
Fortis Malar Hospitals reports consolidated net loss of Rs 0.06 crore in the June 2024 quarter

Net Loss of Fortis Malar Hospitals reported to Rs 0.06 crore in the quarter ended June 2024 as against net loss of Rs 2.93 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 as against Rs 17.76 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales017.76 -100 OPM %0-2.87 - PBDT-0.06-0.25 76 PBT-0.06-2.92 98 NP-0.06-2.93 98 Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Fortis Malar Hospitals to conduct board meeting

Fortis Malar Hospitals will hold a meeting of the Board of Directors of the Company on 22 July 2024.Powered by Capital Market - Live

5 months agoCapital Market - Live

Fortis Malar Hospitals reports consolidated net loss of Rs 1.15 crore in the December 2022 quarter

1 year agoBusiness Standard

Fortis Malar Hospitals appoints Chandrasekar Ramasamy as Whole Time Director and KMP

2 years agoIndia Infoline

Fortis Malar Hospitals reports consolidated net loss of Rs 3.78 crore in the September 2021 quarter

3 years agoBusiness Standard

Top stocks in focus: Aarey Drugs & Pharmaceuticals, Fortis Malar Hospitals, Nath Bio-Genes, Pricol, Gujarat Alkalies and Chemicals

3 years agoIndia Infoline

Fortis Malar Hospitals reports consolidated net loss of Rs 1.34 crore in the June 2021 quarter

3 years agoBusiness Standard